http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27593941

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 7
issn 1177-2727
pageRange 1-7
publicationName Translational Oncogenomics
startingPage 1
bibliographicCitation Sun D, Tainsky MA, Haddad R. Oncogene Mutation Survey in MPNST Cell Lines Enhances the Dominant Role of Hyperactive Ras in NF1 Associated Pro-Survival and Malignancy. Transl Oncogenomics. 2012;5():1–7. PMID: 22346343; PMCID: PMC3273949.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_471ff9c03c98bdf969b64decd642f6d4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff7a8b19655c519c0d34518e875a4656
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c6fe02bdedd3e4b3190daa3739f53db9
date 2012-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC3273949
https://pubmed.ncbi.nlm.nih.gov/22346343
https://doi.org/10.4137/tog.s8830
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/36645
https://portal.issn.org/resource/ISSN/1177-2727
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Oncogene Mutation Survey in MPNST Cell Lines Enhances the Dominant Role of Hyperactive Ras in NF1 Associated Pro-Survival and Malignancy
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8077
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10228
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9149
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8650
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8606c64666a9d2a9531f0e1afb661827
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128368395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128448066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128808200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129635419

Total number of triples: 32.